OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Journey of Von Hippel-Lindau (VHL) E3 ligase in PROTACs design: From VHL ligands to VHL-based degraders
Nisha Setia, Haider Thaer Abdulhameed Almuqdadi, Mohammad Abid
European Journal of Medicinal Chemistry (2023) Vol. 265, pp. 116041-116041
Closed Access | Times Cited: 14
Nisha Setia, Haider Thaer Abdulhameed Almuqdadi, Mohammad Abid
European Journal of Medicinal Chemistry (2023) Vol. 265, pp. 116041-116041
Closed Access | Times Cited: 14
Showing 14 citing articles:
Sequential responsive nano-PROTACs for precise intracellular delivery and enhanced degradation efficacy in colorectal cancer therapy
Liuqing Yang, Ye Yang, Jing Zhang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 7
Liuqing Yang, Ye Yang, Jing Zhang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 7
Unleashing the Power of Covalent Drugs for Protein Degradation
Meng‐Jie Fu, Hang Jin, Shao‐Peng Wang, et al.
Medicinal Research Reviews (2025)
Closed Access
Meng‐Jie Fu, Hang Jin, Shao‐Peng Wang, et al.
Medicinal Research Reviews (2025)
Closed Access
Discovery of a Series of Covalent Ligands That Bind to Cys77 of the Von Hippel–Lindau Tumor Suppressor Protein (VHL)
Simon C. C. Lucas, Sha Liu, Sarah H. Hewitt, et al.
ACS Medicinal Chemistry Letters (2025)
Closed Access
Simon C. C. Lucas, Sha Liu, Sarah H. Hewitt, et al.
ACS Medicinal Chemistry Letters (2025)
Closed Access
Advancements in Proteolysis Targeting Chimeras for Targeted Therapeutic Strategies in Alzheimer’s Disease
Qiuzhi Zhou, Weixia Wang, Chunchu Deng
Molecular Neurobiology (2025)
Open Access
Qiuzhi Zhou, Weixia Wang, Chunchu Deng
Molecular Neurobiology (2025)
Open Access
Recent advances in PROTAC-based antiviral and antibacterial therapeutics
Can Zhou, Shiwei Yang, Jun Wang, et al.
Bioorganic Chemistry (2025), pp. 108437-108437
Closed Access
Can Zhou, Shiwei Yang, Jun Wang, et al.
Bioorganic Chemistry (2025), pp. 108437-108437
Closed Access
Non-Markovian Dynamic Models Identify Non-Canonical KRAS-VHL Encounter Complex Conformations for Novel PROTAC Design
Yunrui Qiu, Rafal Wiewiora, Jesús A. Izaguirre, et al.
(2024)
Open Access | Times Cited: 3
Yunrui Qiu, Rafal Wiewiora, Jesús A. Izaguirre, et al.
(2024)
Open Access | Times Cited: 3
Non-Markovian Dynamic Models Identify Non-Canonical KRAS-VHL Encounter Complex Conformations for Novel PROTAC Design
Yunrui Qiu, Rafal Wiewiora, Jesús A. Izaguirre, et al.
JACS Au (2024) Vol. 4, Iss. 10, pp. 3857-3868
Open Access | Times Cited: 1
Yunrui Qiu, Rafal Wiewiora, Jesús A. Izaguirre, et al.
JACS Au (2024) Vol. 4, Iss. 10, pp. 3857-3868
Open Access | Times Cited: 1
Long noncoding RNAs in ubiquitination, protein degradation, and human diseases
Prarthana Guha, Avisankar Chini, Ashcharya Rishi, et al.
Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms (2024), pp. 195061-195061
Closed Access | Times Cited: 1
Prarthana Guha, Avisankar Chini, Ashcharya Rishi, et al.
Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms (2024), pp. 195061-195061
Closed Access | Times Cited: 1
Advancements in understanding the molecular mechanisms and clinical implications of Von Hippel-Lindau syndrome: A comprehensive review
Y Wang, Jian Song, Shuxing Zheng, et al.
Translational Oncology (2024) Vol. 51, pp. 102193-102193
Open Access | Times Cited: 1
Y Wang, Jian Song, Shuxing Zheng, et al.
Translational Oncology (2024) Vol. 51, pp. 102193-102193
Open Access | Times Cited: 1
Preparation of von Hippel-Lindau (VHL) E3 ubiquitin ligase ligands exploiting constitutive hydroxyproline for benzylic amine protection
Diana M. Soto-Martínez, Garrett D. Clements, John E. Díaz, et al.
RSC Advances (2024) Vol. 14, Iss. 24, pp. 17077-17090
Open Access
Diana M. Soto-Martínez, Garrett D. Clements, John E. Díaz, et al.
RSC Advances (2024) Vol. 14, Iss. 24, pp. 17077-17090
Open Access
Structural Considerations and Chemistry of PROTACs
Abhishek Wahi, Hemant R. Jadhav, Shikha Thakur, et al.
(2024), pp. 39-66
Closed Access
Abhishek Wahi, Hemant R. Jadhav, Shikha Thakur, et al.
(2024), pp. 39-66
Closed Access
Proteolysis Targeting Chimeras (PROTACs): An Innovative Strategy for Targeted Protein Degradation and Disease Treatment
Jun Xia, James K.S. Norris, M. Mackinnon, et al.
International Journal of Drug Discovery and Pharmacology (2024), pp. 100015-100015
Closed Access
Jun Xia, James K.S. Norris, M. Mackinnon, et al.
International Journal of Drug Discovery and Pharmacology (2024), pp. 100015-100015
Closed Access
An overview of GPX4-targeting TPDs for cancer therapy
Xiaojuan Yang, Liqiang Wu, Shaohong Xu
Bioorganic & Medicinal Chemistry (2024) Vol. 118, pp. 118046-118046
Closed Access
Xiaojuan Yang, Liqiang Wu, Shaohong Xu
Bioorganic & Medicinal Chemistry (2024) Vol. 118, pp. 118046-118046
Closed Access
Development of PROTACs targeting estrogen receptor: An emerging technique for combating endocrine resistance
Rouming Peng, Xin Liu, Chun‐Chi Chen, et al.
RSC Medicinal Chemistry (2024)
Closed Access
Rouming Peng, Xin Liu, Chun‐Chi Chen, et al.
RSC Medicinal Chemistry (2024)
Closed Access
